Vial Adaptors for Reconstitution Drug Market: Global Industry Analysis and Forecast (2024-2030)

The Vial Adaptors for Reconstitution Drug Market size was valued at USD 963.21 Million in 2023 and the total Vial Adaptors for Reconstitution Drug revenue is expected to grow at a CAGR of 5.63% from 2024 to 2030, reaching nearly USD 1708.32 Million by 2030.
Vial Adaptors for Reconstitution Drug Market Overview:
Reconstitution is the process of reformulating a dried medication into a state of liquid before administration using a sterile diluent. Reconstitution procedures include numerous processes and often include devices such as a vial adapter, vial-to-vial systems, and complex dual chamber reconstitution systems. Vial adaptors are specialized medical devices designed for the safe and efficient transfer of drugs between vials and syringes and are cost-effective solutions for rapid and healthy transfer. They provide a secure connection, minimizing the risk of needlestick injuries, and maintain a closed environment to prevent leakage. Engineered to fit standard vial sizes they facilitate the precise dosage of medication without significant waste. Many adaptors' improved functionality leads to more efficient drug preparation operations in healthcare settings, which improves patient safety by lowering contamination hazards.

By integrating these devices, healthcare facilities achieve a higher standard of drug administration efficiency and safety. Thus, the demand for vial adaptors has witnessed a significant rise in recent years, eventually supporting the Vial Adaptors for Reconstitution Drug Market growth all across the world. Ensuring the safe and efficient transfer of drugs should be the top priority for healthcare facilities, especially when dealing with hazardous medications. These substances pose significant risks to healthcare professionals through exposure during preparation and administration. The use of vial adaptors eliminates air exposure and direct contact with hazardous drugs, reducing the risk of occupational hazards such as skin irritation or more severe health complications, including higher cancer risks, miscarriages, and chromosomal abnormalities. Technology designed for safe drug transfer creates a safer working environment for healthcare staff while ensuring optimal patient outcomes.

As a result, the rising awareness about the advantages of using vial adaptors in the pharmaceutical industry is expected to be the major factor boosting the vial adaptors for reconstitution drug market growth. For example, According to a September 2021 article published in the National Library of Medicine, chemotherapy drug wasting is a major issue in oncology that not only results in excessive drug costs but also raises the cost of disposing of chemotherapy waste and increases the risk of occupational exposure in the environment. However, adopting a real-time vial-sharing technique with an intelligent robot to dispense numerous prescriptions at once is more affordable. Furthermore, this strategy raised no safety issues, such as the introduction of contaminants into sterile compounding through repeated interspersing or the inaccurate registration of information during medication storage, which is common with standard vial-sharing systems. Thus, such research studies are likely to boost the vial adaptors for reconstitution drug market growth throughout the forecast period.

Rising R&D activities, company business strategies in the development and launch of advanced therapeutics involving biopharmaceuticals, as well as government initiatives aimed at the prevention and management of inflammatory and infectious diseases, are all expected to have a significant impact on the global vial adaptors for reconstitution drug market revenue. All of these factors will not only enhance product availability in the market but will also raise awareness among consumers about the efficacy of biopharmaceuticals. Furthermore, this is likely to raise the consumption of products, which would enhance demand for vials, resulting in market growth. For example, in June 2022, India's Clinical Development Services Agency (CDSA) initiated the Indian Council of Medical Research (ICMR) tuberculosis (TB) vaccination study for healthy households with TB patients. Two possible vaccines were chosen for an ICMR-led Phase III study including 12000 healthy household contacts of sputum smear-positive tuberculosis patients. The CDSA provided research start-up support to all locations and handled the recruitment and immunization of the first participant at the National Institute of Tuberculosis and Respiratory Diseases (NITRD) in New Delhi. As a result, such clinical studies are expected to contribute to the global vial adaptors for reconstitution drug market size.

To know about the Research Methodology :- Request Free Sample Report
Vial Adaptors for Reconstitution Drug Market Trends:
High Demand For Vial Adaptors For Chemotherapy Preparation

A chemotherapy medicine, also called a cytotoxic medicine is a drug that is toxic to human cells. It is used to destroy or eliminate abnormal cells. However, it can also harm healthy cells, therefore proper handling is essential to reduce the risk of damage. These medicines are majority used to treat cancer, leukaemia, and other conditions. There are several chemotherapy medications with numerous applications. To safeguard healthcare personnel against cytotoxic substances, chemotherapy medications have to be handled and prepared with extreme caution. Vial adaptors designed for closed system drug transfer devices (CSTDs) are critical in this context, ensuring that these potent medications are prepared and transferred in a manner that mitigates exposure risks. Thus, increasing demand for vial adaptors for chemotherapy medicines preparations as they offer benefits, is expected to be the key trend in the vial adaptors for the reconstitution drug market and boosting revenue growth.
Vial Adaptors for Reconstitution Drug Market Dynamics:
Strong Use Of Vial Adaptors In Various Medical Settings

Increasing adoption of vial adaptors in various medical applications is expected to be the major factor driving the global vial adaptors for reconstitution drug market. Vial adaptors are vital instruments in a wide range of medical environments, each with its own set of requirements and obstacles. In hospitals, they are used for reconstitution and administration of medications in various departments ranging from oncology to anesthesia. Long-term care facilities utilize vial adaptors for medication preparation and administration, while home care providers may use them for safe and accurate drug transfer. Pharmacists adopt vial adaptors during medicine preparation to maintain sterile conditions while compounding. Research laboratories use vial adaptors for the safe handling and efficient transfer of hazardous substances. The versatility of vial adaptors makes them an essential component in various healthcare applications, promoting consistent efficiency, safety, and accuracy across different medical environments. As a result, strong product demand driving the global vial adaptors for reconstitution drug market size all across the world.

Increasing Prevalence Of Lyophilized Therapeutics

Lyophilization, often known as freeze-drying, is a significant procedure in the global pharmaceutical industry. For many years, the pharmaceutical industry has used freeze-drying processes to improve the shelf life of numerous prescription drugs. According to the MMR findings, nearly 16% of the top 100 pharmaceutical drugs have been lyophilized, and 25% of the biologics market is expected to be lyophilized during the forecast period. More than 30% of the FDA-approved parenteral therapies are lyophilized. The industry is growing for biologics and the storage demands are increasing. The novel drug reconstitution systems market is expected to reach nearly USD 1.5 billion USD by 2025, driven by more complex drug formulations emerging on the market. With the general movement of therapy from the clinic to the home, there is a need for a simple and effective way of reconstituting and administering lyophilized products by a user in a home environment. Hence, the demand for vial adaptors increased significantly, supporting vial adaptors for reconstitution drug market growth.
Vial Adaptors for Reconstitution Drug Market Segment Analysis:
Based on the Therapeutic Area segment, the Metabolic Conditions sub-segment held the largest market share of 36.86% and dominated the global vial adaptors for reconstitution drug market in 2023. In addition, the Infectious Diseases sub-segment held the second dominant position in the global industry in the same year. Vial adaptors have become particularly significant for the treatment of chronic disorders like metabolic problems, where drugs have to be reconstituted before delivery. They improve medication safety and accuracy by minimizing contamination risk and ensuring precise dosing, which is essential for chronic disease management. Additionally, vial adaptors enhance convenience and compliance by simplifying medication preparation and administration, making it easier for patients and caregivers to adhere to treatment regimens while reducing the need for multiple accessories. Vial adaptors are also cost-effective as they reduce medication waste and lower healthcare costs by improving adherence and reducing complications. Infectious diseases also witness significant usage due to the frequent need for injectable treatments that offer quick bioavailability. The adaptors’ role in reproductive health is growing, driven by the increasing use of injectable fertility treatments. Each therapeutic area offers unique requirements for drug reconstitution, influencing the demand for specific types of vial adaptors that can meet the precise treatment needs of patients. These factors collectively boost the segment's market size, and drive the global vial adaptors for reconstitution drug market during the forecast period.


Vial Adaptors for Reconstitution Drug Market Regional Insights:
According to MMR analysis, North America led the global vial adaptors for reconstitution drug market with the highest market share of 34.36% in 2023 and is expected to grow at a CAGR of 9.31% during the forecast period. A significant number of key players, advanced healthcare facilities, strong availability of branded drugs, growing research and development activities government funding and support, etc. factors supported the vial adaptors for reconstitution drug industry growth in North America. In addition, the rising geriatric population which is prone to many chronic diseases such as cancer, increasing the product demand. Almost 58 million adults age 65 and older lived in the United States in 2022, accounting for 17.3% of the nation's population. According to the American Cancer Society, there were an estimated 1.9 million new cancer cases diagnosed and approximately 609,360 cancer deaths in the United States in 2022. Thus, the chemotherapy treatment is in high demand, leading to an increase the product demand, thereby supporting the vial adaptors for reconstitution drug market growth. This is due to, in high-risk environments, such as chemotherapy drug preparation, closed-system vial Adaptors are required to minimize exposure to hazardous drugs. These systems are compatible with chemotherapy protocols, providing a safe transfer mechanism that reduces the risk of contamination and exposure.

Moreover, the substantially growing infectious diseases boosted the vial adaptors for reconstitution drug market in North America. According to the study published in the National Center for Biotechnology Information updated in August 2021, 19.5% of patients in ICU had at least one Hospital Acquired Infection. These infections can be acquired from other patients, hospital staff, or the hospital textiles such as curtains. Likewise, the Sexually Transmitted Infections Treatment Guidelines, 2021, published by the Centers for Disease Control and Prevention, stated that genital herpes is a chronic, lifelong viral infection. Genital herpes can be caused by either HSV-1 or HSV-2. The majority of instances of recurrent genital herpes are caused by HSV-2, and 11.9% of people aged 14 to 49 are estimated to be influenced (436) in the United States. Thus, the increasing prevalence of infectious diseases is expected to increase the consumption of drugs, which is expected to increase vial adaptors thereby supporting the vial adaptors for reconstitution drug market size over the forecast period.



Furthermore, supportive government initiatives and an increase in the number of research partnerships are some of the factors expected to increase the vial adaptors for reconstitution drug market growth rate during the forecast period. The Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021-2025 (Viral Hepatitis Plan), released on January 7, 2021, provides a framework to eliminate viral hepatitis as a public health threat in the United States by 2030. The Viral Hepatitis Plan focuses on hepatitis A, hepatitis B, and hepatitis C are the three most common hepatitis viruses that have the most impact on the health of the nation. The same source is estimated to reduce new hepatitis A virus infections from 4,000 in 2023 to 2,500 in 2028; Hepatitis B virus infections from 18,000 in 2023 to 2,200 in 2028; and Hepatitis C virus infections from 35,000 in 2023 to 4,400 in 2028. Furthermore, growing investments for better analyzing disease models are further expected to drive the vial adaptors for reconstitution drug market. For instance, in April 2021, the government of Canada launched five multidisciplinary infectious disease modeling networks, with a total investment of USD 10 million, to strengthen ties between the academic community, industry, and the public sector. The results will significantly improve the coordination of infectious disease modeling to help Canada better respond to future public health threats, which is expected to lead the vial adaptors for reconstitution drug market all across the world.
Vial Adaptors for Reconstitution Drug Market Scope: Inquire before buying



Global Vial Adaptors for Reconstitution Drug Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US $ 963.21 Mn.


Forecast Period 2024 to 2030 CAGR:
8.53%
Market Size in 2030:
US $ 1708.32 Mn.


 Segments Covered:
by Material
Polycarbonate
Silicon
Polyethylene Teraphthalate Glycol
Polyethylene
Others


by Therapeutic Area
Autoimmune Diseases
Infectious Diseases
Metabolic Conditions
Reproductive Health
Others



Vial Adaptors for Reconstitution Drug Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Leading Vial Adaptors for Reconstitution Drug Market Key Players:
1. Baxter International
2. B. Braun Medical
3. Cardinal Health
4. BD
5. West Pharmaceutical Services
6. Thermo Fisher Scientific
7. Agilent Technologies
8. Shimadzu Corporation
9. McKesson Brands
10. DIDACTIC
11. Eraser Medical
12. ICU Medical
13. Kapsam
14. Smiths Medical Surgivet
15. Sunrise Medical Technology
16. Taizhou Safefusion Medical Instruments
17. Vygon Vet
18. EQUASHIELD
19. Unilife
20. Sensile Medical
21. Dickinson
22. Becton
23. MedXL
24. Helapet
25. Nipro Pharma Packaging India

FAQs:
1. What are the growth drivers for the Vial Adaptors for Reconstitution Drug market?
Ans. Increasing prevalence of chronic and infectious diseases, alongside rising awareness of the advantages of vial adaptors in ensuring medication safety and accuracy are expected to be the major drivers for the Vial Adaptors for Reconstitution Drug market.

2. Which region is expected to lead the global Vial Adaptors for Reconstitution Drug market during the forecast period?
Ans. North America is expected to lead the global Vial Adaptors for Reconstitution Drug market during the forecast period.

3. What is the projected market size and growth rate of the Vial Adaptors for Reconstitution Drug Market?
Ans. The Vial Adaptors for Reconstitution Drug Market size was valued at USD 963.21 Million in 2023 and the total Vial Adaptors for Reconstitution Drug revenue is expected to grow at a CAGR of 5.63% from 2024 to 2030, reaching nearly USD 1708.32 Million by 2030.

4. What segments are covered in the Vial Adaptors for Reconstitution Drug Market report?
Ans. The segments covered in the Vial Adaptors for Reconstitution Drug market report are Material, Therapeutic Area, and Region.